200 related articles for article (PubMed ID: 7622818)
1. The behavioural toxicity of the selective serotonin reuptake inhibitors.
Hindmarch I
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():13-7. PubMed ID: 7622818
[TBL] [Abstract][Full Text] [Related]
2. Fluvoxamine and tricyclic antidepressants (TCAs): how do the TCAs compare as "new" drugs with established fluvoxamine?
Ashford JJ
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():27-31. PubMed ID: 7622820
[TBL] [Abstract][Full Text] [Related]
3. The importance of accidents in evaluating the cost of SSRIs: a review.
Hale AS
Int Clin Psychopharmacol; 1994 Sep; 9(3):195-201. PubMed ID: 7814829
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses.
Taylor D
Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311
[TBL] [Abstract][Full Text] [Related]
6. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.
Whyte IM; Dawson AH; Buckley NA
QJM; 2003 May; 96(5):369-74. PubMed ID: 12702786
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors.
Peretti S; Judge R; Hindmarch I
Acta Psychiatr Scand Suppl; 2000; 403():17-25. PubMed ID: 11019931
[TBL] [Abstract][Full Text] [Related]
8. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants.
Peet M
Br J Psychiatry; 1994 Apr; 164(4):549-50. PubMed ID: 8038948
[TBL] [Abstract][Full Text] [Related]
9. Treatment of severe depression with the selective serotonin reuptake inhibitors.
Schatzberg AF
Depress Anxiety; 1996-1997; 4(4):182-9. PubMed ID: 9166650
[TBL] [Abstract][Full Text] [Related]
10. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
Anderson IM
Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of the pharmacology of serotonin reuptake inhibitors.
Warrington SJ
Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():13-9. PubMed ID: 1484174
[TBL] [Abstract][Full Text] [Related]
12. The effects of antidepressants on psychomotor function with particular reference to reboxetine.
Hindmarch I
Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S17-21; discussion S71-3. PubMed ID: 9169307
[TBL] [Abstract][Full Text] [Related]
13. Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?
Westenberg HG
J Affect Disord; 1996 Sep; 40(1-2):85-93. PubMed ID: 8882918
[TBL] [Abstract][Full Text] [Related]
14. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
Perry PJ
J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
[TBL] [Abstract][Full Text] [Related]
16. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis.
Steffens DC; Krishnan KR; Helms MJ
Depress Anxiety; 1997; 6(1):10-8. PubMed ID: 9394870
[TBL] [Abstract][Full Text] [Related]
17. Choosing between SSRIs and TCAs.
Etminan M
CMAJ; 1998 Feb; 158(4):469, 471. PubMed ID: 9627555
[No Abstract] [Full Text] [Related]
18. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.
Montgomery SA; Henry J; McDonald G; Dinan T; Lader M; Hindmarch I; Clare A; Nutt D
Int Clin Psychopharmacol; 1994; 9(1):47-53. PubMed ID: 8195583
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression.
Mace S; Taylor D
Expert Opin Pharmacother; 2000 Jul; 1(5):917-33. PubMed ID: 11249500
[TBL] [Abstract][Full Text] [Related]
20. Management of patients with depression associated with anxiety symptoms.
Nutt D
J Clin Psychiatry; 1997; 58 Suppl 8():11-6. PubMed ID: 9236730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
